drugset / Trial / NCT00873483

US Ovulation Inhibition Study in Obese Women

NCT00873483

Phase 2 Completed 173 enrolled Bayer
Non-randomizedSingle-groupOpen-labelPrevention

Summary

Birth Control Patch Study

Timeline

Start
2009-04-30
Primary completion
2010-03-03
Completion
2010-03-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Gestodene Small molecule 2.1 mg Other
Subject ethinyl estradiol Small molecule 0.55 mg Other

Indications

No indication recorded.